1 Eyelid Inflammation Drug Market Overview 1.1 Product Overview and Scope of Eyelid Inflammation Drug 1.2 Eyelid Inflammation Drug Segment by Type 1.2.1 Global Eyelid Inflammation Drug Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Antibiotics 1.2.3 Steroids 1.2.4 Others 1.3 Eyelid Inflammation Drug Segment by Application 1.3.1 Global Eyelid Inflammation Drug Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Eyelid Inflammation Drug Market Size Estimates and Forecasts 1.4.1 Global Eyelid Inflammation Drug Revenue 2017-2028 1.4.2 Global Eyelid Inflammation Drug Sales 2017-2028 1.4.3 Eyelid Inflammation Drug Market Size by Region: 2017 Versus 2021 Versus 2028 2 Eyelid Inflammation Drug Market Competition by Manufacturers 2.1 Global Eyelid Inflammation Drug Sales Market Share by Manufacturers (2017-2022) 2.2 Global Eyelid Inflammation Drug Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Eyelid Inflammation Drug Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Eyelid Inflammation Drug Manufacturing Sites, Area Served, Product Type 2.5 Eyelid Inflammation Drug Market Competitive Situation and Trends 2.5.1 Eyelid Inflammation Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Eyelid Inflammation Drug Players Market Share by Revenue 2.5.3 Global Eyelid Inflammation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Eyelid Inflammation Drug Retrospective Market Scenario by Region 3.1 Global Eyelid Inflammation Drug Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Eyelid Inflammation Drug Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Eyelid Inflammation Drug Market Facts & Figures by Country 3.3.1 North America Eyelid Inflammation Drug Sales by Country 3.3.2 North America Eyelid Inflammation Drug Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Eyelid Inflammation Drug Market Facts & Figures by Country 3.4.1 Europe Eyelid Inflammation Drug Sales by Country 3.4.2 Europe Eyelid Inflammation Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Eyelid Inflammation Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Eyelid Inflammation Drug Sales by Region 3.5.2 Asia Pacific Eyelid Inflammation Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Eyelid Inflammation Drug Market Facts & Figures by Country 3.6.1 Latin America Eyelid Inflammation Drug Sales by Country 3.6.2 Latin America Eyelid Inflammation Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Eyelid Inflammation Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Eyelid Inflammation Drug Sales by Country 3.7.2 Middle East and Africa Eyelid Inflammation Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Eyelid Inflammation Drug Historic Market Analysis by Type 4.1 Global Eyelid Inflammation Drug Sales Market Share by Type (2017-2022) 4.2 Global Eyelid Inflammation Drug Revenue Market Share by Type (2017-2022) 4.3 Global Eyelid Inflammation Drug Price by Type (2017-2022) 5 Global Eyelid Inflammation Drug Historic Market Analysis by Application 5.1 Global Eyelid Inflammation Drug Sales Market Share by Application (2017-2022) 5.2 Global Eyelid Inflammation Drug Revenue Market Share by Application (2017-2022) 5.3 Global Eyelid Inflammation Drug Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Bausch Health 6.1.1 Bausch Health Corporation Information 6.1.2 Bausch Health Description and Business Overview 6.1.3 Bausch Health Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Bausch Health Eyelid Inflammation Drug Product Portfolio 6.1.5 Bausch Health Recent Developments/Updates 6.2 Novartis 6.2.1 Novartis Corporation Information 6.2.2 Novartis Description and Business Overview 6.2.3 Novartis Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Novartis Eyelid Inflammation Drug Product Portfolio 6.2.5 Novartis Recent Developments/Updates 6.3 Allergan 6.3.1 Allergan Corporation Information 6.3.2 Allergan Description and Business Overview 6.3.3 Allergan Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Allergan Eyelid Inflammation Drug Product Portfolio 6.3.5 Allergan Recent Developments/Updates 6.4 Laboratoires Thea 6.4.1 Laboratoires Thea Corporation Information 6.4.2 Laboratoires Thea Description and Business Overview 6.4.3 Laboratoires Thea Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Laboratoires Thea Eyelid Inflammation Drug Product Portfolio 6.4.5 Laboratoires Thea Recent Developments/Updates 6.5 Akorn 6.5.1 Akorn Corporation Information 6.5.2 Akorn Description and Business Overview 6.5.3 Akorn Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Akorn Eyelid Inflammation Drug Product Portfolio 6.5.5 Akorn Recent Developments/Updates 6.6 NovaBay Pharmaceuticals 6.6.1 NovaBay Pharmaceuticals Corporation Information 6.6.2 NovaBay Pharmaceuticals Description and Business Overview 6.6.3 NovaBay Pharmaceuticals Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.6.4 NovaBay Pharmaceuticals Eyelid Inflammation Drug Product Portfolio 6.6.5 NovaBay Pharmaceuticals Recent Developments/Updates 6.7 Scope Ophthalmics 6.6.1 Scope Ophthalmics Corporation Information 6.6.2 Scope Ophthalmics Description and Business Overview 6.6.3 Scope Ophthalmics Eyelid Inflammation Drug Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Scope Ophthalmics Eyelid Inflammation Drug Product Portfolio 6.7.5 Scope Ophthalmics Recent Developments/Updates 7 Eyelid Inflammation Drug Manufacturing Cost Analysis 7.1 Eyelid Inflammation Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Eyelid Inflammation Drug 7.4 Eyelid Inflammation Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Eyelid Inflammation Drug Distributors List 8.3 Eyelid Inflammation Drug Customers 9 Eyelid Inflammation Drug Market Dynamics 9.1 Eyelid Inflammation Drug Industry Trends 9.2 Eyelid Inflammation Drug Market Drivers 9.3 Eyelid Inflammation Drug Market Challenges 9.4 Eyelid Inflammation Drug Market Restraints 10 Global Market Forecast 10.1 Eyelid Inflammation Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Eyelid Inflammation Drug by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Eyelid Inflammation Drug by Type (2023-2028) 10.2 Eyelid Inflammation Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Eyelid Inflammation Drug by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Eyelid Inflammation Drug by Application (2023-2028) 10.3 Eyelid Inflammation Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Eyelid Inflammation Drug by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Eyelid Inflammation Drug by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Eyelid Inflammation Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Eyelid Inflammation Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Eyelid Inflammation Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Eyelid Inflammation Drug Market Competitive Situation by Manufacturers in 2021 Table 5. Global Eyelid Inflammation Drug Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Eyelid Inflammation Drug Sales Market Share by Manufacturers (2017-2022) Table 7. Global Eyelid Inflammation Drug Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Eyelid Inflammation Drug Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Eyelid Inflammation Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Eyelid Inflammation Drug Manufacturing Sites and Area Served Table 11. Manufacturers Eyelid Inflammation Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Eyelid Inflammation Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eyelid Inflammation Drug as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Eyelid Inflammation Drug Sales by Region (2017-2022) & (K Units) Table 16. Global Eyelid Inflammation Drug Sales Market Share by Region (2017-2022) Table 17. Global Eyelid Inflammation Drug Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Eyelid Inflammation Drug Revenue Market Share by Region (2017-2022) Table 19. North America Eyelid Inflammation Drug Sales by Country (2017-2022) & (K Units) Table 20. North America Eyelid Inflammation Drug Sales Market Share by Country (2017-2022) Table 21. North America Eyelid Inflammation Drug Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Eyelid Inflammation Drug Revenue Market Share by Country (2017-2022) Table 23. Europe Eyelid Inflammation Drug Sales by Country (2017-2022) & (K Units) Table 24. Europe Eyelid Inflammation Drug Sales Market Share by Country (2017-2022) Table 25. Europe Eyelid Inflammation Drug Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Eyelid Inflammation Drug Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Eyelid Inflammation Drug Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Eyelid Inflammation Drug Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Eyelid Inflammation Drug Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Eyelid Inflammation Drug Revenue Market Share by Region (2017-2022) Table 31. Latin America Eyelid Inflammation Drug Sales by Country (2017-2022) & (K Units) Table 32. Latin America Eyelid Inflammation Drug Sales Market Share by Country (2017-2022) Table 33. Latin America Eyelid Inflammation Drug Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Eyelid Inflammation Drug Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Eyelid Inflammation Drug Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Eyelid Inflammation Drug Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Eyelid Inflammation Drug Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Eyelid Inflammation Drug Revenue Market Share by Country (2017-2022) Table 39. Global Eyelid Inflammation Drug Sales by Type (2017-2022) & (K Units) Table 40. Global Eyelid Inflammation Drug Sales Market Share by Type (2017-2022) Table 41. Global Eyelid Inflammation Drug Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Eyelid Inflammation Drug Revenue Share by Type (2017-2022) Table 43. Global Eyelid Inflammation Drug Price by Type (2017-2022) & (US$/Unit) Table 44. Global Eyelid Inflammation Drug Sales (K Units) by Application (2017-2022) Table 45. Global Eyelid Inflammation Drug Sales Market Share by Application (2017-2022) Table 46. Global Eyelid Inflammation Drug Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Eyelid Inflammation Drug Revenue Share by Application (2017-2022) Table 48. Global Eyelid Inflammation Drug Price by Application (2017-2022) & (US$/Unit) Table 49. Bausch Health Corporation Information Table 50. Bausch Health Description and Business Overview Table 51. Bausch Health Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Bausch Health Eyelid Inflammation Drug Product Table 53. Bausch Health Recent Developments/Updates Table 54. Novartis Corporation Information Table 55. Novartis Description and Business Overview Table 56. Novartis Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Novartis Eyelid Inflammation Drug Product Table 58. Novartis Recent Developments/Updates Table 59. Allergan Corporation Information Table 60. Allergan Description and Business Overview Table 61. Allergan Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Allergan Eyelid Inflammation Drug Product Table 63. Allergan Recent Developments/Updates Table 64. Laboratoires Thea Corporation Information Table 65. Laboratoires Thea Description and Business Overview Table 66. Laboratoires Thea Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Laboratoires Thea Eyelid Inflammation Drug Product Table 68. Laboratoires Thea Recent Developments/Updates Table 69. Akorn Corporation Information Table 70. Akorn Description and Business Overview Table 71. Akorn Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Akorn Eyelid Inflammation Drug Product Table 73. Akorn Recent Developments/Updates Table 74. NovaBay Pharmaceuticals Corporation Information Table 75. NovaBay Pharmaceuticals Description and Business Overview Table 76. NovaBay Pharmaceuticals Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. NovaBay Pharmaceuticals Eyelid Inflammation Drug Product Table 78. NovaBay Pharmaceuticals Recent Developments/Updates Table 79. Scope Ophthalmics Corporation Information Table 80. Scope Ophthalmics Description and Business Overview Table 81. Scope Ophthalmics Eyelid Inflammation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Scope Ophthalmics Eyelid Inflammation Drug Product Table 83. Scope Ophthalmics Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Eyelid Inflammation Drug Distributors List Table 87. Eyelid Inflammation Drug Customers List Table 88. Eyelid Inflammation Drug Market Trends Table 89. Eyelid Inflammation Drug Market Drivers Table 90. Eyelid Inflammation Drug Market Challenges Table 91. Eyelid Inflammation Drug Market Restraints Table 92. Global Eyelid Inflammation Drug Sales Forecast by Type (2023-2028) & (K Units) Table 93. Global Eyelid Inflammation Drug Sales Market Share Forecast by Type (2023-2028) Table 94. Global Eyelid Inflammation Drug Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Eyelid Inflammation Drug Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Eyelid Inflammation Drug Sales Forecast by Application (2023-2028) & (K Units) Table 97. Global Eyelid Inflammation Drug Sales Market Share Forecast by Application (2023-2028) Table 98. Global Eyelid Inflammation Drug Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Eyelid Inflammation Drug Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Eyelid Inflammation Drug Sales Forecast by Region (2023-2028) & (K Units) Table 101. Global Eyelid Inflammation Drug Sales Market Share Forecast by Region (2023-2028) Table 102. Global Eyelid Inflammation Drug Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Eyelid Inflammation Drug Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Eyelid Inflammation Drug Figure 2. Global Eyelid Inflammation Drug Market Share by Type in 2021 & 2028 Figure 3. Antibiotics Product Picture Figure 4. Steroids Product Picture Figure 5. Others Product Picture Figure 6. Global Eyelid Inflammation Drug Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Clinic Figure 9. Others Figure 10. Global Eyelid Inflammation Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Eyelid Inflammation Drug Market Size (2017-2028) & (US$ Million) Figure 12. Global Eyelid Inflammation Drug Sales (2017-2028) & (K Units) Figure 13. Eyelid Inflammation Drug Sales Share by Manufacturers in 2021 Figure 14. Global Eyelid Inflammation Drug Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Eyelid Inflammation Drug Players: Market Share by Revenue in 2021 Figure 16. Eyelid Inflammation Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Eyelid Inflammation Drug Sales Market Share by Region (2017-2022) Figure 18. Global Eyelid Inflammation Drug Sales Market Share by Region in 2021 Figure 19. Global Eyelid Inflammation Drug Revenue Market Share by Region (2017-2022) Figure 20. Global Eyelid Inflammation Drug Revenue Market Share by Region in 2021 Figure 21. United States Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. China Taiwan Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Mexico Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Brazil Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Argentina Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Turkey Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Saudi Arabia Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. UAE Eyelid Inflammation Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Sales Market Share of Eyelid Inflammation Drug by Type (2017-2022) Figure 44. Manufacturing Cost Structure of Eyelid Inflammation Drug Figure 45. Manufacturing Process Analysis of Eyelid Inflammation Drug Figure 46. Eyelid Inflammation Drug Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Bausch Health Novartis Allergan Laboratoires Thea Akorn NovaBay Pharmaceuticals Scope Ophthalmics